Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

The Cooper Companies, Inc. (NYSE:COO - Get Rating) - Equities research analysts at Jefferies Financial Group cut their FY2022 earnings per share (EPS) estimates for Cooper Companies in a research note issued on Wednesday, August 31st. Jefferies Financial Group analyst Z. Weiner now expects that the medical device company will earn $12.78 per share for the year, down from their previous estimate of $13.24. The consensus estimate for Cooper Companies' current full-year earnings is $13.13 per share. Jefferies Financial Group also issued estimates for Cooper Companies' FY2024 earnings at $15.89 EPS and FY2025 earnings at $17.70 EPS.

Cooper Companies (NYSE:COO - Get Rating) last posted its quarterly earnings results on Wednesday, August 31st. The medical device company reported $3.19 earnings per share for the quarter, missing the consensus estimate of $3.24 by ($0.05). Cooper Companies had a return on equity of 9.48% and a net margin of 30.20%. The firm had revenue of $843.40 million for the quarter, compared to the consensus estimate of $830.22 million. During the same quarter in the previous year, the company posted $3.41 EPS. The firm's revenue was up 10.5% compared to the same quarter last year.

COO has been the subject of several other reports. Stifel Nicolaus reduced their price target on Cooper Companies from $475.00 to $450.00 in a research report on Monday, June 6th. Robert W. Baird cut their price objective on shares of Cooper Companies from $375.00 to $345.00 and set a "neutral" rating for the company in a research report on Thursday. Stephens decreased their target price on shares of Cooper Companies from $500.00 to $460.00 and set an "overweight" rating on the stock in a report on Friday, June 3rd. TheStreet downgraded shares of Cooper Companies from a "b-" rating to a "c+" rating in a report on Monday, July 18th. Finally, KeyCorp reduced their price target on shares of Cooper Companies from $414.00 to $408.00 and set an "overweight" rating for the company in a research report on Friday, June 3rd. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat, Cooper Companies presently has an average rating of "Moderate Buy" and an average target price of $413.67.Cooper Companies Stock Performance

NYSE COO opened at $300.12 on Friday. Cooper Companies has a 12-month low of $283.03 and a 12-month high of $463.59. The firm has a market cap of $14.81 billion, a P/E ratio of 15.76, a price-to-earnings-growth ratio of 2.22 and a beta of 0.90. The company has a quick ratio of 0.69, a current ratio of 1.05 and a debt-to-equity ratio of 0.33. The company's 50 day moving average is $314.91 and its 200-day moving average is $353.53. Hedge Funds Weigh In On Cooper Companies

Institutional investors have recently modified their holdings of the company. Riverview Trust Co bought a new stake in Cooper Companies in the 1st quarter worth approximately $29,000. Trust Co. of Vermont bought a new stake in shares of Cooper Companies in the 2nd quarter worth approximately $27,000. Parkside Financial Bank & Trust boosted its stake in shares of Cooper Companies by 65.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the medical device company's stock valued at $30,000 after purchasing an additional 38 shares in the last quarter. Clear Street Markets LLC grew its holdings in shares of Cooper Companies by 410.0% during the 2nd quarter. Clear Street Markets LLC now owns 102 shares of the medical device company's stock valued at $32,000 after purchasing an additional 82 shares during the last quarter. Finally, Ellevest Inc. raised its position in Cooper Companies by 82.4% in the 2nd quarter. Ellevest Inc. now owns 124 shares of the medical device company's stock worth $39,000 after purchasing an additional 56 shares during the period. 97.09% of the stock is currently owned by institutional investors. Cooper Companies Dividend Announcement

The company also recently declared a semi-annual dividend, which was paid on Thursday, August 11th. Shareholders of record on Wednesday, July 27th were paid a dividend of $0.03 per share. The ex-dividend date of this dividend was Tuesday, July 26th. Cooper Companies's dividend payout ratio (DPR) is currently 0.32%. About Cooper Companies (Get Rating)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.Read MoreGet a free copy of the StockNews.com research report on Cooper Companies (COO)Lululemon Set To Soar Into SeptemberCould Nike Stock be Oversold, but Still Overvalued?Is Alcoa A Buy After Strong Q2 Results And More Share Buybacks?Will Royal Caribbean's Broadband Partnership Drive Revenue?Chip Gear Maker Entegris Has Potential, But Is It Buyable Now?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Tom remains optimistic about investors’ prospects going forward, even as the market reacts to the words of Fed Chair Jerome Powell about “pain ahead.”

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.